Controversy Kicks Up Over A Drug Meant To Prevent Premature Birth Enlarge this image toggle caption Jill Lehmann Photography/Getty Images Jill Lehmann Photography/Getty Images An independent panel of advisers to the Food and Drug Administration recommended last week that a medication to prevent preterm birth be taken off the market because, the advisers decided, the preponderance of evidence suggests it …
